Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Jasmonates induce Arabidopsis bioactivities selectively inhibiting the growth of breast cancer cells through CDC6 and mTOR. | New Phytol | 2021 | 33124043 | PubTator, text mining | PubMed |
| Exploiting Replication Stress as a Novel Therapeutic Intervention. | Mol Cancer Res | 2021 | 33020173 | PubTator, text mining | PubMed |
| The shifting shape and functional specializations of the cell cycle during lineage development. | WIREs Mech Dis | 2021 | 32916032 | PubTator, text mining | PubMed |
| CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme. | Clin Transl Oncol | 2021 | 32661826 | PubTator, text mining | PubMed |
| E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice. | Hepatology | 2021 | 32259305 | PubTator, text mining | PubMed |
| miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6. | Minerva Med | 2021 | 32166936 | PubTator, text mining | PubMed |
| DNA Replication Control: Liquid-liquid Phase Separation Comes Into Play. | J Mol Biochem | 2020 | 36532101 | PubTator, text mining | PubMed |
| Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers. | Explor Target Antitumor Ther | 2020 | 36046486 | PubTator, text mining | PubMed |
| Construction of a potential microRNA, transcription factor and mRNA regulatory network in hepatocellular carcinoma. | Transl Cancer Res | 2020 | 35117917 | PubTator, text mining | PubMed |
| Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis. | Transl Cancer Res | 2020 | 35117787 | PubTator, text mining | PubMed |
| The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma. | Transl Cancer Res | 2020 | 35117502 | PubTator, text mining | PubMed |
| LncRNA XIST acts as a ceRNA sponging miR-185-5p to modulate pancreatic cancer cell proliferation via targeting CCND2. | Transl Cancer Res | 2020 | 35117490 | PubTator, text mining | PubMed |
| Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report. | JTO Clin Res Rep | 2020 | 34589930 | PubTator, text mining | PubMed |
| FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis. | Front Oncol | 2020 | 33680951 | PubTator, text mining | PubMed |
| Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer. | Front Oncol | 2020 | 33634028 | PubTator, text mining | PubMed |
| Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1. | Front Pharmacol | 2020 | 33628185 | PubTator, text mining | PubMed |
| An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers. | Front Genet | 2020 | 33424936 | PubTator, text mining | PubMed |
| Analysis of Hub Genes Involved in Distinction Between Aged and Fetal Bone Marrow Mesenchymal Stem Cells by Robust Rank Aggregation and Multiple Functional Annotation Methods. | Front Genet | 2020 | 33424919 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies. | Front Oncol | 2020 | 33415077 | PubTator, text mining | PubMed |
| Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary. | Front Genet | 2020 | 33408743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=52